Elif Sikoglu, PhD
Elif provides scientific oversight for clinical trials utilizing imaging across CNS indications including neuro-oncology, neuro-degenerative diseases, neuro-psychiatry and rare diseases. She has significant experience in consulting on imaging-based clinical trial endpoint determination and operationalization. She leads the development and the standardization of complex image acquisition guidelines, and has been instrumental in the development and the implementation of imaging assessment criteria and analysis methods, working extensively with key-opinion-leaders. She has initiated and has developed key partnerships to enhance Calyx’s CNS offerings particularly integrating quantitative analysis and AI. Prior to joining Calyx, Elif was a post-doctoral researcher at University of Massachusetts (UMASS) Medical School Psychiatry department where she worked on application of advanced MRI modalities for neuropsychiatric diseases in clinical populations as well as translational pre-clinical models.